Back To Search Instructions
Protocols
19 protocols meet the specified criteria
Disease Site: Breast - Female
Protocol No.TitleStatus
0600000101Sentinel Lymph Node Working Group Data Acquisition ProjectOpen
0600000477DATABASE FOR INDIVIDUALS AT HIGH RISK FOR BREAST, OVARIAN AND OTHER HEREDITARY CANCERSOpen
0800000099BREAST MAMMOGRAPHIC DENSITY MEASUREMENT: COMPARISON OF RADIOGRAPHIC AND DIFFUSION MRI IMAGING TECHNIQUESOpen
0800000599Use of Remnant Skin from Mastectomy for Development of Skin Cancer BiomarkersOpen
1000000366Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast CancerOpen
1000000478 I-SPY 2 TRIAL : (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) Open
1100000607A phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-stage Breast Cancer RTOG 1005Open
1200000080NSAID Effects on Clinical and Imaging Breast BiomarkersOpen
1200000138Biospecimen Repository for Individuals at High Risk for Breast, Ovarian, or Other Hereditary CancersOpen
1200000513S1008 Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase IIOpen
1300000027S1207, "Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer."Open
1300000477A Single-arm Phase II Trial to Evaluate Serum Estradiol Levels in Patients with Breast Cancer Treated with Vaginal Estrogen, EstringOpen
1300000483Chronic Oral Bicarbonate Feasibility StudyOpen
1300000596Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk Open
1300000612A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced or Refractory Solid Tumors or Lymphoma Open
1300000688Concurrent Xeloda and RT for Breast CancerOpen
1300000710A single arm Phase II trial to assess association of BRCA1 protein expression with overall response rate in patients with metastatic breast cancer on pegylated liposomal doxorubicinOpen
1402213408Multicenter, Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of Fulvestrant (Faslodex®) With or Without PD 0332991 (palbociclib) ± Goserelin in Women with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Whose Disease Progressed After Prior Endocrine Therapy.Open
1402224036A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer Open